DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo

GlaxoSmithKline (NYSE: GSK)

42.26 0.12 (0.28%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GSK $42.26 0.28%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $42.33
Previous Close $42.14
Daily Range $42.07 - $42.40
52-Week Range $41.25 - $54.78
Market Cap $102.1B
P/E Ratio 14.52
Dividend (Yield) $2.31 (6.0%)
Ex-Dividend Date
Dividend Pay Date
05/13/15
07/09/15
Volume 2,103,906
Average Daily Volume 3,925,062
Current FY EPS $2.45

Sector

Healthcare

Industry

Drug Makers

GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website: http://www.gsk.com/

News & Commentary

3 Reasons I Have Little Confidence in GlaxoSmithKline's Dividend

GlaxoSmithKline is yielding nearly 6% on a trailing 12-month basis, but these three factors have the potential to dramatically cut its payout in the coming years.

Week In Review: Zhongheng Pays $52 Million For Oramed's Diabetes Drugs

GlaxoSmithKline: An Undervalued 'Work In Progress'

Sector's Smaller Players Show The Way

PSA: Afrezza Is NOT Exubera

Premarket Biotech Digest: Gilead Files TAF NDA, Pristiq Goes Generic, Biocept Surges 7%

Premarket Biotech Digest: Celgene-Juno, AbbVie Rx Data, FDA-Gilead Lawsuit

Best 3 Yielding Buy-Rated Stocks: VLY, LHO, GSK

Wall Street is Betting Big Against These 3 Biotechs

Biotech stocks have had a huge run recently, and now Wall Street is betting heavily against these 3 recent winners.

Vertex Pharma: Well Positioned To Set New Highs

See More GSK News...

GSK's Top Competitors

GSK $42.26 (0.28%)
Current stock: GSK
RHHBY $35.18 (0.10%)
Current stock: RHHBY
JNJ $98.44 (-0.03%)
Current stock: JNJ
PFE $33.37 (-0.95%)
Current stock: PFE